| Role of excitatory amino acid transporter‐2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics K Kim, SG Lee, TP Kegelman, ZZ Su, SK Das, R Dash, S Dasgupta, ... Journal of cellular physiology 226 (10), 2484-2493, 2011 | 468 | 2011 |
| Astrocyte elevated gene-1 induces protective autophagy SK Bhutia, TP Kegelman, SK Das, B Azab, Z Su, SG Lee, D Sarkar, ... Proceedings of the National Academy of Sciences 107 (51), 22243-22248, 2010 | 134 | 2010 |
| Oncogene AEG-1 Promotes Glioma-Induced Neurodegeneration by Increasing Glutamate Excitotoxicity SG Lee, K Kim, TP Kegelman, R Dash, SK Das, JK Choi, L Emdad, ... Cancer research 71 (20), 6514-6523, 2011 | 120 | 2011 |
| MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanoma SK Das, SK Bhutia, B Azab, TP Kegelman, L Peachy, PK Santhekadur, ... Cancer research 73 (2), 844-854, 2013 | 101 | 2013 |
| Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin TP Kegelman, B Wu, SK Das, S Talukdar, JM Beckta, B Hu, L Emdad, ... Proceedings of the National Academy of Sciences 114 (2), 370-375, 2017 | 95 | 2017 |
| MDA-9/syntenin: a positive gatekeeper of melanoma metastasis SK Das, SK Bhutia, TP Kegelman, L Peachy, RA Oyesanya, S Dasgupta, ... Front Biosci 17 (1), 1-15, 2012 | 89 | 2012 |
| MDA-9/syntenin is a key regulator of glioma pathogenesis TP Kegelman, SK Das, B Hu, MD Bacolod, CE Fuller, ME Menezes, ... Neuro-oncology 16 (1), 50-61, 2014 | 68 | 2014 |
| Astrocyte elevated gene-1 interacts with Akt isoform 2 to control glioma growth, survival, and pathogenesis B Hu, L Emdad, MD Bacolod, TP Kegelman, XN Shen, MA Alzubi, SK Das, ... Cancer research 74 (24), 7321-7332, 2014 | 63 | 2014 |
| Targeting tumor invasion: the roles of MDA-9/Syntenin TP Kegelman, SK Das, L Emdad, B Hu, ME Menezes, P Bhoopathi, ... Expert opinion on therapeutic targets 19 (1), 97-112, 2015 | 60 | 2015 |
| In vivo modeling of malignant glioma: the road to effective therapy TP Kegelman, B Hu, L Emdad, SK Das, D Sarkar, PB Fisher Advances in Cancer Research 121, 261-330, 2014 | 42 | 2014 |
| mda‐7/IL‐24 differentially regulates soluble and nuclear clusterin in prostate cancer SK Bhutia, SK Das, TP Kegelman, B Azab, R Dash, Z Su, XY Wang, ... Journal of cellular physiology 227 (5), 1805-1813, 2012 | 42 | 2012 |
| Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules M Hedvat, L Emdad, S K Das, K Kim, S Dasgupta, S Thomas, B Hu, S Zhu, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2012 | 33 | 2012 |
| Astrocyte elevated gene-1 regulates β-catenin signaling to maintain glioma stem-like stemness and self-renewal B Hu, L Emdad, TP Kegelman, XN Shen, SK Das, D Sarkar, PB Fisher Molecular Cancer Research 15 (2), 225-233, 2017 | 32 | 2017 |
| AEG-1/MTDH/LYRIC: a promiscuous protein partner critical in cancer, obesity, and CNS diseases L Emdad, SK Das, B Hu, T Kegelman, DC Kang, SG Lee, D Sarkar, ... Advances in cancer research 131, 97-132, 2016 | 32 | 2016 |
| Astrocyte elevated gene-1 activates AMPK in response to cellular metabolic stress and promotes protective autophagy SK Bhutia, TP Kegelman, SK Das, B Azab, ZZ Su, SG Lee, D Sarkar, ... Autophagy 7 (5), 547-548, 2011 | 20 | 2011 |
| Suppression of prostate cancer pathogenesis using an MDA-9/Syntenin (SDCBP) PDZ1 small-molecule inhibitor SK Das, TP Kegelman, AK Pradhan, XN Shen, P Bhoopathi, S Talukdar, ... Molecular Cancer Therapeutics 18 (11), 1997-2007, 2019 | 19 | 2019 |
| The quest for an effective treatment for an intractable cancer: established and novel therapies for pancreatic Adenocarcinoma BA Quinn, NA Lee, TP Kegelman, P Bhoopathi, L Emdad, SK Das, ... Advances in Cancer Research 127, 283-306, 2015 | 14 | 2015 |
| Factors associated with fatigue in patients with breast cancer undergoing external beam radiation therapy MJ LaRiviere, HH Chao, A Doucette, TP Kegelman, NK Taunk, ... Practical Radiation Oncology 10 (6), 409-422, 2020 | 9 | 2020 |
| Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint … N Yegya-Raman, SH Lee, C Friedes, X Wang, M Iocolano, TP Kegelman, ... Radiotherapy and Oncology 190, 110005, 2024 | 6 | 2024 |
| Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer N Yegya-Raman, TP Kegelman, SH Lee, MJ Kallan, KN Kim, J Natarajan, ... Clinical and Translational Radiation Oncology 39, 100581, 2023 | 3 | 2023 |
